CP50: Merck & Co. Inc.
Merck & Co. Inc. is a pharmaceutical manufacturer based in Whitehouse Station, N.J., most noted for its hypertension and cholesterol combating drugs, as well as vaccines for conditions such as measles and mumps. The company achieved sales of $24.2 billion and net income of $3.3 billion in 2007. The company employs 59,800 people across four geographical regions, including the United States; Europe, Middle East and Africa; Japan; and a miscellaneous area categorized as Other. The company was established in 1891.
President and CEO
Kenneth Frazier served as president of Merck, with responsibility for the companys three major divisions: Global Human Health, Mercks pharmaceutical and vaccine business; Merck Manufacturing Division, Mercks manufacturing and supply division; and Merck Research Laboratories, Mercks research organization. Ken served as executive vice president and president, Global Human Health, from 2007 to May 2010, when he became Merck president.He entered his current role in 2011.
Executive Vice President and President, Merck Manufacturing Division
Willie Deese was appointed executive vice president of Mercks Manufacturing Division in 2008. He served as president from 2005-2007. He previously served as senior vice president, Global Procurement from 2004-2005. He joined Merck in 2004.
Executive Vice President, Chief Ethics and Compliance Officer
Holston has served as executive vice president and chief ethics and compliance officer since 2012. He previously served as executive vice president, general counsel and board secretary for Hewlett-Packard Company between 2007 and 2012. He also was the assistant U.S. attorney for the U.S. Department of Justice’s criminal division in the Eastern District of Pennsylvania from 1990 to 1993.
For the latest financial reports, visit: http://www.merck.com/finance
- Merck & Co. Inc.
- 1 Merck Dr.
- Whitehouse Station, N.J. 08889-0100
Featured content related to Merck & Co. Inc.
Merck & Co. Inc. Articles
ProductsMerck’s key products include Cozaar/Hyzarr, medicines for the treatment of hypertension;
Gardasil, a vaccine for the prevention of cervical cancer and genital warts caused by certain types of HPV, Januvia, a medicine for the treatment of type 2 diabetes; Singulair, a once-a-day oral medicine for the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction; Vytorin, a medicine to treat the two sources of cholesterol marketed through the Merck/Schering-Plough joint venture; Zetia, a cholesterol-absorption inhibitor marketed through the Merck/Schering-Plough joint venture